HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

4-iodo-3-nitrobenzamide

a PARP1 inhibitor with antineoplastic activity
Also Known As:
BSI 201; BSI-201; BSI201; iniparib
Networked: 35 relevant articles (8 outcomes, 17 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Charpentier, Eric: 2 articles (11/2015 - 12/2014)
2. Garcia-Ribas, Ignacio: 2 articles (11/2015 - 12/2014)
3. Carlson, Robert W: 2 articles (06/2015 - 12/2014)
4. O'Shaughnessy, Joyce: 2 articles (12/2014 - 01/2011)
5. Winer, Eric P: 2 articles (12/2014 - 08/2014)
6. de Bono, Johann S: 2 articles (12/2013 - 12/2011)
7. Bradley, Charles: 2 articles (04/2011 - 01/2011)
8. Kirsten, Eva: 2 articles (09/2009 - 02/2002)
9. Hakam, Alaeddin: 2 articles (09/2009 - 02/2002)
10. Kun, Ernest: 2 articles (09/2009 - 02/2002)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Ovarian Neoplasms (Ovarian Cancer)
4. Pancreatic Neoplasms (Pancreatic Cancer)
5. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

Related Drugs and Biologics

1. Carboplatin (JM8)
2. gemcitabine
3. irinotecan (Camptosar)
4. Reactive Oxygen Species (Oxygen Radicals)
5. Platinum
6. Type I DNA Topoisomerases (Topoisomerase I)
7. Paclitaxel (Taxol)
8. 4-iodo-3-nitrobenzamide
9. 2- ((R)- 2- methylpyrrolidin- 2- yl)- 1H- benzimidazole- 4- carboxamide
10. Cisplatin (Platino)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Neoadjuvant Therapy
3. Stents